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Abstract
Background: RIG-I is a pivotal receptor that detects numerous RNA and DNA viruses. Thus, its defectiveness may strongly
impair the host antiviral immunity. Remarkably, very little information is available on RIG-I single-nucleotide polymorphisms
(SNPs) presenting a functional impact on the host response.
Methodology/Principal Findings: Here, we studied all non-synonymous SNPs of RIG-I using biochemical and structural
modeling approaches. We identified two important variants: (i) a frameshift mutation (P229fs) that generates a truncated,
constitutively active receptor and (ii) a serine to isoleucine mutation (S183I), which drastically inhibits antiviral signaling and
exerts a down-regulatory effect, due to unintended stable complexes of RIG-I with itself and with MAVS, a key downstream
adapter protein.
Conclusions/Significance: Hence, this study characterized P229fs and S183I SNPs as major functional RIG-I variants and
potential genetic determinants of viral susceptibility. This work also demonstrated that serine 183 is a residue that critically
regulates RIG-I-induced antiviral signaling.
Citation: Pothlichet J, Burtey A, Kubarenko AV, Caignard G, Solhonne B, et al. (2009) Study of Human RIG-I Polymorphisms Identifies Two Variants with an
Opposite Impact on the Antiviral Immune Response. PLoS ONE 4(10): e7582. doi:10.1371/journal.pone.0007582
Editor: David M. Ojcius, University of California Merced, United States of America
Received August 4, 2009; Accepted October 1, 2009; Published October 27, 2009
Copyright:  2009 Pothlichet et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was partially funded by the Institut Pasteur through three ‘‘Programme Transversal de Recherche’’ (PTR#186, PTR#I224 and PTR#202) and
by the French national research agency (ANR-MIE-Flupropar and ANR-MIE-Evolsensors). Alexander N. R. Weber and Andriy V. Kubarenko are funded by Deutsche
Forschungsgemeinschaft and Deutsches Krebsforschungszentrum. Gregory Caignard is supported by a ‘‘Bourse de Docteur Ingenieur’’ from Centre National de la
Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: sitahar@pasteur.fr
Introduction
Among all viral components that trigger the antiviral screen of the
host, nucleic acids have been viewed as the most important [1]. In
mammals, there are at least two receptor systems in place to detect
such viral motifs and to further mount a type I interferon (IFN)-
dependent antiviral immune response. The endosomal TLR3, 7, 8,
and 9 interact with extracellular viral nucleic acids while the cytosolic
helicases RIG-I and MDA-5 sense intracellular double-stranded
(ds)RNA and/or 59triphosphate single-stranded RNA, two common
byproducts of viral infection and replication [2,3,4,5].
Current knowledge posits RIG-I as a particularly critical
surveillance molecule that detects numerous viruses such as the
human pathogens influenza and hepatitis C (HCV) viruses [6,7].
RIG-I interacts with its ligands by means of its central ATP-binding
helicase domain as well as its carboxyterminal regulatory domain
(RD; see the schematic representation in Fig. 1A). Via its amino-
terminal tandem Caspase Recruitment Domains (CARDs), RIG-I
homocomplexes relay a signal by binding MAVS (also known as IPS-
1, CARDIF or VISA), an adapter protein that mediates CARD-
dependent interactions with RIG-I. This signaling complex further
activates the transcription factors NF-kB and interferon regulatory
factor (IRF)-3 to ultimately upregulate the expression of pro-
inflammatory and antiviral mediators and the subsequent induction
of adaptive immune responses [2,3,4].
Importantly, the receptor function of RIG-I is non-redundant, as
confirmed by knock-out studies [8]. Moreover, the Huh7.5
hepatocytic cell line is especially permissive to HCV as the result of
an elaborate viral evasion strategy as well as to a defective RIG-I
protein bearing a single mutation [9,10]. In that regard, unequivocal
evidence shows that genetic mutations may be important determi-
nants of increased susceptibility to viral diseases [11,12]. Among
them, single-nucleotide polymorphisms (SNPs) are DNA sequence
variations that occur when a single nucleotide is altered. There are
more than 4 million SNPs in the human genome, 200,000 of which
occur in coding regions, underlying the extent of genetic variability
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7582and its potential positive or negative effects on the host antimicrobial
defense [13,14]. Interestingly, studies aiming to characterize RIG-I
polymorphisms are scarce. Here, we characterized functional effects
of two RIG-I SNPs that might help us to understand the basis of
individual variations between normal and abnormal innate immune
responses to viral pathogens as well as to better appreciate the
molecular mechanism by which RIG-I is triggered by non-self RNA.
Results
Genetic variability profile of human RIG-I
Information collected on 04/2009 from NCBI SNP database
indicates that at least 342 SNPs are present in the human RIG-I
gene. Among them, 14 are situated within coding sequences but
only 7 result in amino acids substitutions, i.e. R7C, S144F, S183I,
T260P, I406T, D580E, F789L (Fig. 1A). An additional SNP
corresponds to a thymidine insertion at nucleotide position 845
of RIG-I mRNA (accession number NM_014314), which results in
a frameshift (fs) and in a truncated RIG-I protein. This mutant is
herein defined as P229fs as it includes the first 229 residues (instead
of 925 residues in the WT RIG-I protein) followed by 4
unintended residues (i.e. FRSV; Fig. 1B) and thus, does not
contain the helicase and the RD domains. As illustrated in Fig. 1A,
RIG-I SNPs map to the different domains of the protein.
Next, we found by sequence alignments, that the S183I, T260P,
I406T and D580E mutations affect amino acids that are rather
conserved in all analyzed species, whereas R7C, S144F and F789L
affect residues conserved only in higher mammals (Fig. 1B). In
regard to RIG-I SNP frequency in a healthy randomly selected
human population, the NCBI SNP database provides such
information for only three SNPs among the eight described here
(R7C, D580E and F789L; Fig. 1C). The frequency values provided
are very low and may suggest a negative selection of these SNPs
due to their impact on RIG-I function. To check this hypothesis,
we further studied the functional impact of all missenses SNPs on
RIG-I function.
Missense SNPs differentially affect RIG-I-mediated innate
immune signaling
Elucidating the functional role of non-synonymous SNPs in
RIG-I may enhance our understanding of viral pathogenesis and
host defense mechanisms as well as to contribute to a more
detailed knowledge in structure-function relationship of RIG-I. To
this effect, plasmids containing the eight SNPs were generated by
site-directed PCR mutagenesis. We first observed that R7C, S144F,
S183I, P229fs, T260P, I406T, D580E, F789L mutations did not alter
expression and/or stability of RIG-I protein using western-blot
(Fig. 2A) and flow cytometry (Fig. 2B) analyses. Also, the molecular
weight of all RIG-I proteins was similar, with the exception of
P229fs RIG-I which resulted in a truncated protein with a size
comparable to the 2CARD module (Fig. 2A).
To determine whether non-synonymous SNPs can alter RIG-I-
induced antiviral and/or pro-inflammatory signaling pathways, we
used a functional cell-based assay to evaluate RIG-I-dependent
activation of an IFN-b promoter or an NF-kB- or IRF-3-
dependent promoter, respectively. We first checked the level of
constitutive activation of the RIG-I constructs in absence of any
stimulus in HEK 293T or BEAS-2B cells. Fig. 2C shows a
moderate but highly significant constitutive IFN-b expression and
IRF-3 activity -but no NF-kB activity (not shown)- in WT RIG-I-
transfected cells (n=3, p,0.001 when compared to control vector-
expressing cells), in agreement with the fact that RIG-I is especially
prominent in signaling pathways leading to type I IFNs [2,3,4,15].
Interestingly, IFN-b expression and IRF-3 activity in cells
expressing T260P, I406To rF 789L mutants was similar to that
induced by WT RIG-I and lower in cells expressing the R7C,
S144F, or D580E RIG-I (n=3, p#0.0002). With regard to P229fs
RIG-I, we observed a salient constitutive IFN-b and NF-kB
reporter activities, at a level well above that induced by the
full-length form of WT RIG-I (n=3, p,0.0001; Fig. 2D). In
addition, P229fs SNP induces the expression of endogenous
inflammatory and antiviral chemokines such as IL-8 and
RANTES, respectively (Fig. 2E), at a level comparable to that
Figure 1. Genetic variability profile of human RIG-I. (A) Schematic representation of major domains of RIG-I (adapted from [7,17,34]). RIG-I
non-synonymous SNPs described in NCBI SNP database are indicated as R7C (rs10813831), S144F (rs55789327), S183I (rs11795404), P229frameshift (fs)
(rs36055726), T260P (rs35527044), I406T (rs951618), D580E (rs17217280) and F789L (rs35253851). (B) Alignment of protein sequence of RIG-I SNPs from
human to platypus, using ClustalW software. Amino acids in blue and red correspond to conserved and non-conserved residues, respectively. (C)
Frequency of RIG-I SNPs alleles. This latter information was collected from NCBI SNP database and refers to the sum of SNP containing alleles in both
homozygous and heterozygous individuals for a given SNP. ND: not determined.
doi:10.1371/journal.pone.0007582.g001
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important as it suggests that individuals carrying such mutation
may constitutively produce exaggerated amounts of immune
mediators.
By contrast, no constitutive IFN-b expression was triggered by
the S183I RIG-I mutant (n=3, p,0.0001; Fig. 2C). More
importantly, S183I SNP uniquely inhibited IRF-3 (not shown),
IFN-b and NF-kB reporter activities elicited by the viral mimetic
poly(I:C), in agreement with previous studies that have shown that
poly(I:C) is a potent RIG-I stimulus ([16,17,18,19]; Fig. 3A; n=3
p,0.0001). To confirm the pathophysiological relevance of the
above findings, we sought to address the responsiveness of the
mutant proteins to viral infection. We clearly demonstrated that
S183I mutation had a deleterious effect on RIG-I antiviral activity
as it drastically reduced IFN-b and NF-kB-mediated responses
triggered by intact, replicative Sendai or influenza A viruses
(Fig. 3B and 3C). Noteworthy, while R7C SNP slightly inhibited
RIG-I signaling triggered by Sendai virus stimulation, D580E
inhibited RIG-I signaling in response to dsRNA and IAV, but not
to Sendai virus infection (n=3, p#0.003). Nevertheless, as S183I
SNP uniquely resulted in the strongest inhibition of RIG-I-
dependent signaling induced by all stimuli, we decided to focus the
rest of our study on this specific mutation. Thus, the clear loss-of-
function effect of S183I RIG-I SNP was confirmed by measuring
the secretion of IL-8 (n=3 p,0.0001; Fig. 3D) and RANTES (not
illustrated) in the supernatants of stimulated HEK 293T cells. This
result well extends Shigemoto et al.’s findings using RIG-I-deficient
murine embryonic fibroblasts [20]. Finally, specificity controls are
Figure 2. RIG-I-mediated constitutive innate immune signaling,
but not expression level, is differentially affected by RIG-I
SNPs. Expression of wild-type (WT) and non-synonymous SNPs RIG-I as
assessed by western-blot using BEAS-2B cells (A) and flow cytometry (B)
using an anti-Flag antibody and BEAS-2B and/or HEK 293T cells 42 h
post-transfection. RIG-I SNP proteins are expressed at the same level as
WT RIG-I with the exception of P229fs in BEAS-2B cells. (C–E) BEAS-2B
(grey bars) and/or HEK 293T cells (black bars) were co-transfected with a
b-galactosidase reporter plasmid and either a NF-kB-, IRF-3 or IFN-b-
luciferase-reporter plasmid and a vector encoding WT (empty bars) or
SNPs RIG-I (filled bars) (C–E) or WT 2CARD (E) or a control plasmid. Data
were collected 42 h (C)o r2 4 h( D–E) post-transfection and are
expressed as the mean 6 SD of RLU normalized to b-galactosidase
activity of triplicate samples minus basal activity measured in empty
vector-transfected cells (C–D). One representative experiment out of
three is shown. // in (C) means that this condition was not tested. (E)
Stimulated HEK 293T cells as shown in panels (D) were assessed for IL-8
and RANTES release by ELISA. Data are mean 6 SD of triplicate samples
and are representative of three independent experiments.
doi:10.1371/journal.pone.0007582.g002
Figure 3. SNPs differentially modulate RIG-I-mediated immune
signaling in response to a viral dsRNA mimetic as well as to
influenza A and Sendai viruses. HEK 293T cells (A–B) and BEAS-2B
cells (C) were co-transfected with WT (open bars) or non-synonymous
SNP RIG-I (black bars) expression vectors and IFN-b or NF-kB-dependent
luciferase reporter plasmids. 24 h later, cells were challenged for 18 h
by poly(I:C) (p(I:C), 1 mg/well) (A) or infected with Sendai virus (SeV, 2
HAU/well) (B) or influenza A virus (IAV, MOI=1) (C). Data are expressed
as in Fig. 2c and are representative of three independent experiments.
// in (B) means that this condition was not tested. (D) The stimulated or
infected cells as shown in panels (A–B) were subsequently assessed for
IL-8 release by ELISA. Data are mean 6 SD of triplicate samples and are
representative of three independent experiments. IL-8 was undetect-
able in supernatants of non-stimulated transfected cells. (E)S 183I SNP
does not alter RIG-I-independent signaling. BEAS-2B and HEK 293T cells
were co-transfected with WT or S183I RIG-I vectors or empty vector
(control) and a NF-kB-dependent luciferase reporter plasmid. 24 h later
cells were stimulated with PMA (100 nM) or TNF-a (20 ng/ml).
doi:10.1371/journal.pone.0007582.g003
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variant is specific to the RIG-I-dependent pathway. Thus, NF-kB
signaling in HEK 293T or BEAS2B cells triggered by two non-
viral stimuli (i.e. the cytokine TNFa and the potent PKC signaling
activator PMA) was not down-modulated by S183I RIG-I, in
comparison with WT RIG-I (Fig. 3E). Altogether, these data
stressed the critical role of S183 residue in mediating RIG-I-
induced innate immune signaling.
RIG-I 2CARD module carrying the S183I SNP is unable to
trigger signal transduction
Next, we investigated the mechanism by which S183I SNP
results in inhibition of RIG-I antiviral immune response. First, we
found that this was neither due to an alteration at a very early step
of RIG-I signaling, i.e. the ligand-binding capacity (Fig. 4A) nor to
a RIG-I cellular mislocalization (not illustrated). In a very recent
report, Fujita’s laboratory also demonstrated that the inhibitory
phenotype of S183I RIG-I was neither due to a failure of
ubiquitination [20]; a post-translational process essential for
RIG-I activity [21]. Next, we took advantage of the fact that the
isolated tandem WT 2CARD elicits a vigorous and spontaneous
induction of downstream signaling [7] to examine whether S183I
mutation could also inhibit this constitutive cell response. As
shown in Fig. 4B, contrary to WT 2CARD, the S183I 2CARD
could not induce IFN-b and NF-kB activities in HEK 293T (n=3,
p,0.0001) and BEAS-2B cells (not shown). This loss-of-function
effect was confirmed by measuring the secretion of endogenous
mediators in supernatants of HEK 293T cells (n=3, p,0.0001;
Fig. 4C).
RIG-I isoleucine 183 residue closes off RIG-I homodimers
and RIG-I/MAVS complexes
CARD domains mediate homotypic or heterotypic interactions
to promote signaling events [22,23]. It is therefore possible that
S183I SNP inhibits downstream signaling by altering RIG-I
oligomerization or RIG-I/MAVS interaction. To test this
hypothesis, we first examined the formation of RIG-I complexes
between WT or S183I RIG-I and the constitutively active WT
2CARD. A detailed kinetic analysis revealed that this oligomer-
ization process was dynamic with WT RIG-I complexes detectable
as early as 16 h and a peak of interaction at 30 h post-transfection
followed by a dissociation 40 h post-transfection (n=6; Fig. 5A).
Remarkably, we observed that S183I RIG-I formed a more
prominent complex with WT 2CARD at any time point,
suggesting that this SNP increases RIG-I self-association.
Previous studies have demonstrated that RIG-I engages MAVS
through CARD-mediated interactions, leading to the activation of
downstream transcriptional factors essential for effective antiviral
responses [2,3,4]. Thus, we further assessed whether S183I SNP
could also influence RIG-I/MAVS complex formation. Using a
co-immunoprecipitation approach, a kinetic analysis first revealed
that WT 2CARD/MAVS interaction was also dynamic with
complexes detectable in cells transfected with vectors encoding
WT proteins, as early as 18 h and increasing at 30 h post-
transfection (n=3; Fig. 5B). Remarkably, we observed that S183I
SNP also enhanced 2CARD/MAVS complexes (Fig. 5B) as well as
full-length RIG-I/MAVS interaction induced by Sendai virus
(Fig. 5C). Collectively, our data reveal the importance of S183 in
the transient complex formation that is required for proper RIG-I-
mediated signaling pathways and strongly support the hypothesis
that regulation of RIG-I/RIG-I and RIG-I/MAVS association/
dissociation constitutes a major checkpoint of this antiviral
signaling.
As S183I is located in the RIG-I second CARD (CARD#2)
domain, we next postulated that this paradoxical enhancing effect
of S183I SNP might be due to CARD structure alteration. Using
sequence alignment information (cf. Fig. S1) and a previously
described homology modeling approach [24], we generated three-
dimensional homology models for the RIG-I CARD#2 structure
as well as its S183I variant. As shown in Fig. 5D, residue 183 is
located on the helix 6 of CARD#2. Interestingly, when subjected
to a 10 ns molecular dynamics simulation (last frame shown in
Fig. 5D; intermediate frames illustrating behavior during simula-
tion are available in Fig. S2), WT and mutant structures behaved
differently as to the position of helix 6. Whereas in the WT protein
helix 6 is at a approximately 60u angle to the remaining helices, in
the S183I variant, helix 6 is tightly packed in an almost parallel
way, leading to differences in surface structure and hydrophobicity
(Figs. 5E,F). For instance, WT CARD#2 shows a hydrophobic
patch involving I187 and V188 in the vicinity of S183, whereas this
patch is absent in the mutant structure and a new hydrophobic
patch surrounds I132. While the overall charge distribution appears
unchanged, the relative spatial arrangement of charged residues is
altered by the S183I substitution (Fig. 5F, see e.g. the negatively
charged E176,E 184 or the positively charged K169,K 172,K 177 and
K181). Additionally, comparison of the movement of secondary
structure elements over the course of the simulation suggests the
S183I structure is less flexible than the WT structure (Fig. S3).
S183I SNP exerts a down-modulatory effect
Phenotypes of several heritable disorders are linked to missense
mutations in single alleles. In some cases, the mutant protein
exhibits a regulatory effect whereby heterozygous co-expression of
mutant and WT gene has a deleterious consequence, relatively to
the case in which two WT alleles are expressed [25,26]. Such a
down-regulatory effect usually involves homomeric or heteromeric
proteins. In regard to the ability of S183I SNP to impair antiviral
Figure 4. Analysis of the loss-of-function mechanism of S183I
SNP: evidence for an inhibition of the constitutive signal
transduction triggered by 2CARD RIG-I. (A)S 183I does not affect
dsRNA binding activity of RIG-I as assessed by a pull-down of Flag-
tagged WT and S183I RIG-I proteins using poly(I:C)-coated agarose
beads, 42 h after transfection of HEK 293T cells. (B, C)S 183I strongly
inhibits RIG-I 2CARD-induced IFN-b-dependent antiviral and NF-kB-
dependent pro-inflammatory signaling as demonstrated by luciferase
reporter assays (B) or by measuring RANTES and IL-8 release by ELISA in
HEK 293T cells (C) co-transfected for 42 h with WT or S183I 2CARD or
empty expression vector and luciferase reporter plasmids. Data are
mean 6 SD of triplicate samples and are representative of three
independent experiments.
doi:10.1371/journal.pone.0007582.g004
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I/MAVS heterocomplexes, it might be speculated that in a
heterozygous host, the mutant protein would interfere with the
function of the normal protein being produced from the WT allele.
To test this hypothesis, we titrated WT RIG-I with increasing
amounts of S183I RIG-I in mock treated-HEK 293T and in HEK
293T cells activated by the viral mimetic poly(I:C) or infected by
Sendai virus (Fig. 6, panels A–C). As a single example, IFN-b
response was reduced by ,50% in cells co-transfected with an
equimolar concentration of WT RIG-I and S183I RIG-I
expressing vectors and further activated by these stimuli (n=3,
p,0.0001). We also observed that this S183I 2CARD mutant
reduced IFN-b activity of WT 2CARD by ,50% when
transfected at a 1:1 ratio and up to 70% at a fourfold excess of
transfected plasmid DNA (n=3, p,0.0001, Fig. 6D). Interestingly,
the negative impact of S183I SNP was less potent when considering
Figure 5. S183I RIG-I SNP increases RIG-I/RIG-I and RIG-I/MAVS interactions. (A) Kinetic of 2CARD/RIG-I interaction was analyzed in HEK 293T
cells co-transfected with biotin-WT RIG-I or biotin-S183I RIG-I and Flag-WT 2CARD expression vectors. Biotin-RIG-I proteins were pull-downed and
revealed as described in Methods section. (B) Kinetic of 2CARD/MAVS interaction was assessed in HEK 293T cells co-transfected with V5-WT or S183I
2CARD and Flag-MAVS. MAVS was immunoprecipitated with an anti-Flag antibody and interaction with 2CARD was revealed by immunoblot with an
anti-V5 antibody. (C) Full-length RIG-I/MAVS interaction was evaluated in HEK 293T cells co-transfected with biotin-WT or -S183I RIG-I and Flag-MAVS
expression vectors for 25 h and infected with Sendai virus for 19 h. MAVS was immunoprecipitated as in (B) and complexes with RIG-I were detected
with streptavidin-HRP. IP: immunoprecipitation; PD: pull-down; IB: immunoblot. (D–F) Structural modeling suggests differences between WT and
S183I second CARD (CARD#2) domain of RIG-I. (D) a three-dimensional homology model of the CARD#2 (residues 92–193) of WT (left) and S183I
(right) RIG-I was subjected to a 10 ns molecular dynamics simulation. The last frame is shown. Helices are numbered and color coded and amino acid
183 shown in pink and boxed. As evident, helix a (a) 6, which harbors amino acid I183, shows a different spatial orientation. (E) Surface hydrophobicity
is affected by this structural rearrangement, in particular a small patch surrounding I187 and V188 in WT (left), and I132 in S183I (right) CARD#2,
respectively. Hydrophobicity near the N-terminus of H1 is due to truncation of the protein chain (CARD1 missing) and subsequent exposure of areas
otherwise buried in full-length RIG-I. Hydrophilic areas shown in blue, hydrophobic areas in green. (F) Overall surface charge is similar in the WT (left)
and S183I (right) structure but individual charged residues are positioned differently. Negative charge shown in red, positive charge in blue.
doi:10.1371/journal.pone.0007582.g005
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2CARD or Sendai virus, consistently with the primary role of
RIG-I in type I-IFN-inducing antiviral signaling pathways
[2,3,4,27].
Discussion
The efforts conducted by international consortiums – such as
the HapMap Project and Perlegen – to identify and characterize
the levels of polymorphic variation in humans has yielded an ever-
growing list of SNPs [28]. These include variation located in genes
involved in innate immunity, which may account for individual
differences in the response to pathogens. For instance, mutations
in TLR2, TLR4, TLR5 and IRAK4 have all been associated with
increased risk to develop infectious diseases [13,29,30]. In regard
to genes encoding CARD-containing proteins, mutations in the
peptidoglycan receptors NOD1 and NOD2 have been associated
to several inflammatory disorders, including Crohn’s disease, Blau
syndrome and asthma [23]. A non-synonymous SNP in MDA-5
was also reported to show an association with type I diabetes [31].
Remarkably, no human disease has yet been linked to RIG-I.
Nonetheless, the defective response of a human hepatoma cell line,
found permissive to HCV replication, was due to a single mutation
(T55I) [9,21,32]. Here, we characterized functional effects of RIG-
I SNPs that might help us to understand the basis of individual
variations between normal and abnormal innate immune
responses to viral pathogens as well as to better appreciate the
molecular mechanism by which RIG-I is triggered by non-self
RNA.
Among the eight RIG-I SNPs reported in NCBI SNP database,
we characterized two distinct functional SNPs which strongly alter
RIG-I-mediated signaling. First, we identified P229fs as a SNP
which results in a truncated constitutively active RIG-I. This
finding is particularly important as it suggests that individuals
carrying such mutation may constitutively produce exaggerated
amounts of antiviral and pro-inflammatory mediators. Conversely,
in agreement with a very recent study from T. Fujita’s laboratory
[20], we characterized the loss-of-function S183I SNP. Interesting-
ly, this natural mutation allowed us to further demonstrate the
importance of S183 in the transient complex formation that is
required for proper RIG-I signaling. Thus, our findings strongly
support the hypothesis that regulation of RIG-I/RIG-I and
RIG-I/MAVS association/dissociation constitutes a major check-
point of this antiviral signaling pathway.
CARDs-containing proteins are members of a large group of the
‘death domain superfamily’, which also include the DD (death
domain) subfamily and the DED (death effector domain) subfamily.
All these domains have a six-helical bundle (H1–H6) structural fold
and mediate homotypic interactions within each domain subfamily
[22,33,34]. At the amino acid level, the CARD#2d o m a i no fR I G - I
differsfromotherCARDs(seealignmentinFig.S1),whosemolecular
structures have been previously determined (e.g. MAVS, Apaf-1,
RAIDD, Nod1 [22]). We predicted the CARD#2 three-dimensional
structure by using comparative/homology modeling in an approach
similar to that taken by Potter et al. (where MDA-5 and RIG-I
CARD#1 were modeled on a experimentally determined MAVS
C A R Dc r y s t a ls t r u c t u r e )[ 3 4 ] .W ew e r et h u sa b l et ov i s u a l i z et h e
structural implications of the S183I SNP. In our model, serine 183
maps to helix H6 (cf. Ref. [34]. In molecular dynamics studies, which
allowed to assess protein flexibility, H6 with S183 appeared quite
flexible and moved perpendicular to the remaining helices incontrast
to H6 with I183 which seemed more rigid. More pertinent, our
findings suggest that the replacement of a hydrophilic serine by a
hydrophobic isoleucine may alter the flexibility as well as the surface
architecture of the CARD#2 domain, in particular the exposure of
hydrophobic areas. These changes may enhance and/or stabilize
hydrophobic interactions in H6, critical for CARD-CARD interac-
tions between RIG-I per se as well as with MAVS. This hypothesis is
consistent with studies that have established that hydrophobic
residues put constraints on the relative orientations of protein helices
[35]; this process being critical for CARD-CARD complex structures
[22,34,36]. While additional structural studies outside the scope of
this work will be necessary to fully uncover the structural impact of
the S183I mutation, our in silico analysis points to a potential impact
on the basis of helical packing in the RIG-I CARD#2d o m a i n .
Collectively, on the basis of the data presented here, we consider
that serine 183 residue plays a central role in the molecular
ordering that leads to RIG-I-mediated NF-kB and IRF-3
activation pathways. Nevertheless, one can wonder how S183I
SNP inhibits RIG-I-induced signaling pathways despite its
enhancing effect on RIG-I complexes formation. Based on our
biochemical assays and structural modeling showing that this
mutation does affect hydrophobicity and flexibility of the
CARD#2 domain of RIG-I but does not influence its ligand
binding activity, we hypothesize that S183I rather induces an
abortive conformation of RIG-I, rendering it incapable of
downstream signaling. Concerning the inhibitory effect of S183I
on RIG-I/MAVS-dependent signal transduction, a recent study
clearly supports the concept that MAVS association with RIG-I is
not per se sufficient for inducing immune gene expression [37].
Thus, a splicing form of MAVS called MAVS 1a, which shares
little sequence similarity with WT MAVS but still contains CARD
domain as well as a TRAF-binding motif, can interact strongly
with RIG-I but cannot trigger cell signaling. Therefore, like S183I,
expression of MAVS 1a interferes with the formation of
Figure 6. Down-regulatory effect of S183I RIG-I SNP. (A–C)S 183I
exerts a down-modulatory effect on full-length WT RIG-I-mediated
responses as revealed by IFN-b and NF-kB-dependent reporter assays
with HEK 293T cells transfected at different ratio with WT RIG-I and/or
S183I RIG-I vectors. An empty vector was used to maintain the total
plasmid quantity constant. Data represent the mean 6 SD of
percentage of inhibition by S183I RIG-I of WT RIG-I-dependent
constitutive responses (A, ‘‘mock’’), or after Sendai virus infection (B),
or after challenge by poly(I:C) (p(I:C); C) of triplicate samples. (d)S 183I
exerts a down-regulatory effect on WT 2CARD-induced antiviral, but not
on pro-inflammatory, responses. HEK 293T cells were transfected as in
(A–C) except that expression of full-length WT or S183I RIG-I was
replaced by the corresponding 2CARD modules. Data represent the
mean 6 SD of percentage of inhibition by S183I 2CARD of WT 2CARD-
dependent constitutive responses measured in triplicate samples. (A–
D) are representative of three independent experiments.
doi:10.1371/journal.pone.0007582.g006
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contributes to its inhibitory outcome.
Elucidating the functional role of RIG-I SNPs may enhance our
understanding of the pathogenesis of viral infections, to ultimately
decrease morbidity and mortality through improved risk assess-
ment and early administration of prophylactic therapies [13,29].
Clinical studies assessing S183I SNP frequency in control healthy
individuals and patients infected by viruses will certainly clarify the
contribution of RIG-I variation to the pathogenesis of viral
diseases. Likewise, investigating the clinical relevance of the potent
immunostimulatory P229fs SNP may be particularly interesting in
patients with autoimmune diseases where cytokines play a pivotal
pathogenic role. Among them, evidence linking IFN-a/b with the
pathogenesis of lupus and insulin-dependent diabetes mellitus in
humans are the most convincing [38]. Meanwhile, our study
demonstrates that serine 183 is a pivotal residue involved in
communication between CARD modules of RIG-I themselves as
well as with MAVS and emphasizes the complexity of molecular
events that governs RIG-I-induced antiviral signaling.
Materials and Methods
Viruses and reagents
Influenza/A/Scotland/20/74 (H3N2) virus was prepared as
previously described [39]. Sendai virus (Cantell strain, ATCC
VR-907 Parainfluenza 1) was a kind gift of E. Meurs (Institut
Pasteur, Paris, France). The viral dsRNA mimetic polyinosinic:
polycytidylic acid (poly(I:C)) and phorbol 12-myristate 13-acetate,
(PMA) were from Sigma. Human recombinant TNFa was
purchased from Peprotech.
Phylogenetic analysis of RIG-I SNPs
RIG-I SNPs were as described in NCBI’s SNP database (cf.
http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?locusId=23586).
RIG-I sequences from human to platypus were aligned using
EMBL ClustalW software and manually arranged.
Plasmids construction and site-directed mutagenesis
The pEFBOS(+)-Flag-RIG-I (amino acids 2–925) or 2CARD
(amino acids 2–229) vectors were previously described [17] and
pcDNA3-Flag-MAVS and pCI-V5-WT 2CARD plasmids were a
kind gift of Dr. Z. Chen and Dr. E. Meurs, respectively. SNPs
containing plasmids were made using the QuickChange II XL
Site-Directed Mutagenesis kit (Stratagene). Sequences of oligonu-
cleotides used for mutagenesis are indicated in Table S1. An in vitro
recombination-based cloning (Gateway system; Invitrogen) was
used to generate biotin-tagged WT or S183I RIG-I, as previously
described [40]. Briefly, biotin-tagged RIG-I (WT or S183I)
expression vectors were generated by PCR using pEFBOS(+)-
Flag RIG-I as a template and the following forward (59-ggggacaac-
tttgtacaaaaaagttggcatgACCACCGAGCAGCGACGCA-39) and
reverse primers (59-ggggacaactttgtacaagaaagttggttaTTTGGACA-
TTTCTGCTGGATCAAATGG-39), as well as the Gateway
technology for a final cloning in pcDNA6/BioEase-DEST plasmid
(Invitrogen), according to manufacturer’s instructions.
All constructs were entirely sequenced to confirm that no
unintended mutations were generated during PCR reaction.
Cell culture, transfection, ELISA and luciferase assays
Detailed protocols were described before [39]. Data are
expressed as the mean (610
23) of relative luciferase units (RLU)
normalized with b-galactosidase activity minus basal activity
measured in empty vector-transfected cells.
Immunoblot and protein-protein interactions analysis
EK 293T cells were transiently co-transfected with 1 mg of Flag-
tagged MAVS or V5-tagged 2CARD vectors (for tandem
2CARD/MAVS interaction analysis) or 3 mg of Flag-tagged
2CARD and biotin-conjugated RIG-I vectors (for tandem
2CARD/RIG-I interaction). After cell disruption and a pre-
clearing step, pull-down of biotin-tagged RIG-I was performed
using streptavidin sepharose beads (GE Healthcare). For
co-immunoprecipitation assay, cell lysates were incubated with a
monoclonal anti-Flag M2 antibody, followed by the addition of
protein G sepharose beads. More detailed protocols can be
provided upon request. After centrifugation and protein denatur-
ation, samples were analyzed by immunoblot as described in
reference [39].
dsRNA binding assay
Assay of dsRNA binding activity of RIG-I (WT or S183I) was
previously described [41]. Briefly, HEK 293T cells were seeded in
100 mm tissue culture dishes and transiently transfected with 8 mg
of control plasmid or vector encoding Flag-tagged RIG-I (WT or
S183I). 48 h post-transfection, cells were disrupted in 1.5 ml of
RIPA lysis buffer and 400 mg of cell lysates were incubated with
poly(I:C)- or control poly(C)-coated agarose beads (Sigma) in
RIPA lysis buffer supplemented with proteases inhibitors cocktail
and 50 U/ml of RNAse inhibitor (Promega) for 1 h at 4uC.
Agarose beads were then collected by centrifugation and washed
three times with lysis buffer before resuspension in 30 ml sample
denaturating buffer.
Flow cytometry and fluorescence microscopy analysis.
To evaluate RIG-I (WT or SNP) protein expression levels and
subcellular localization, BEAS-2B and HEK 293T cells were
transfected and processed as previously described [42], using the
following antibodies: anti-Flag antibody (2 mg/ml) and Alexa
488-
conjugated secondary antibody (4 mg/ml, A11001, Molecular
probes).
Computational modeling and structural analysis of RIG-I
CARD#2
Homology modeling and molecular dynamics of the human
RIG-I CARD#2 domain were carried out as previously described
by Kubarenko et al. [24] based on several CARD domain
structures: 1cww [43], 2vgq [34], 3crd [44], 1dgn [45] and 2b1w
[46]. The sequence identity for 2vgq and RIG-I CARD domains is
between 21–26.8% (depending on the alignment algorithm used).
The method of comparative/homology modeling was therefore
applied [47]. Structure analysis was carried using the following
software (referenced in [24]) SwissPBD Viewer and PyMol (www.
pymol.org) for visualization; HotPatch [48] for hydrophobicity
and PDB2PQR [49], PropKa [50] and APBS [51] for charged
surface calculation. Further details are available on request.
Statistical analysis
Statistical differences were tested using a one-way ANOVA
followed by a Fisher test, with a threshold of p,0.05.
Supporting Information
Table S1 Plasmids containing SNPs were made by site-directed
mutagenesis using the QuickChange II XL Site-Directed Muta-
genesis kit (Stratagene), 125 ng of specific forward and reverse
primers and 25 ng of RIG-I WT vector as a template in 50 ml
reaction volume. After an initial denaturation step at 95uC for
1 min, mutagenesis was performed by 18 cycles of amplification
(1 min at 95uC, 50 s at 60uC and 9 min 30 s at 68uC), followed by
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digestion by DpnI restriction enzyme and transformation of
bacteria were performed according to manufacturer’s instructions.
Found at: doi:10.1371/journal.pone.0007582.s001 (0.03 MB
DOC)
Figure S1 Alignment of amino acid sequence of CARD#2
domain of RIG-I with other CARD structures. Alignment of
CARD domain sequences from different CARD proteins which
were used for RIG-I CARD#2 modeling. Helix 1 colored in red,
helix 2 in orange, helix 3 in yellow, helix 4 in green, helix 5 in blue
and helix 6 in brown. For Apaf1, MAVS, RAIDD, ICEBERG and
NOD1 CARDs, helix boundaries were determined directly from
the respective PDB files 1cww, 2vgq, 3crd, 1dgn and 2b1w, based
on a 3D alignment of these structures.
Found at: doi:10.1371/journal.pone.0007582.s002 (0.91 MB
DOC)
Figure S2 Intermediate frames of WT and S183I CARD#2
structures during molecular dynamic simulation. Eleven frames
from the molecular dynamics simulation of RIG-I CARD#2W T
(A) or S183I mutant (B), showing one frame per picosecond. First
frame (0 ps) corresponds to the initial raw model conformation.
Helixes from 1 to 6 are rainbow-colored, helix 6 which harbors
S183 is colored red.
Found at: doi:10.1371/journal.pone.0007582.s003 (4.28 MB
DOC)
Figure S3 Comparison of the stability of WT and S183I
CARD#2 structures over the course of molecular dynamic
simulation. Root mean square deviation (RMSD) calculated from
10 ps molecular dynamics simulation mapped onto the initial raw
models of WT RIG-I CARD#2 (A) or S183I mutant (B)
structures. More stable elements are colored green, more flexible
regions in red.
Found at: doi:10.1371/journal.pone.0007582.s004 (1.37 MB
DOC)
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